Startups
A world without dementia STARTS TODAY Targeting Neurodegeneration Upstream with Precision Neuroscience Learn More
Overview
Location
United States
Employees
1-10
Founded date
2015
Investors 2
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
| MassChallenge | masschallenge.org |
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Sep 29, 2020 | MassChallenge Names Top 48 Finalist Startups From 2020 Austin, Boston, Houston, and Rhode Island Cohorts | Global network for innovators begins to identify top startups and geographies of top innovators launching groundbreaking, fundable businesses and plans to share trends at October 22, 2020 streaming event. (Boston, MA – September 29, 2020) ... |
| Jun 2, 2020 | MassChallenge Boston Announces 2020 Cohort | JUNE 2, 2020 (BOSTON, MA) - MassChallenge, a global network of zero-equity startup accelerators, today announced the 100 early-stage startups that will join the 2020 MassChallenge Boston program. These startups have been rigorously selected... |
Reviews 0
FAQ about Cogentis Therapeutics
When was Cogentis Therapeutics founded?
Cogentis Therapeutics was founded in 2015.
Who has invested in Cogentis Therapeutics?
Parsers VC lists 2 investors of Cogentis Therapeutics, among them MassChallenge.
What has the press written about Cogentis Therapeutics?
Parsers VC has collected 3 articles mentioning Cogentis Therapeutics, among them “MassChallenge Names Top 48 Finalist Startups From 2020 Austin, Boston, Houston, and Rhode Island Cohorts” (Sep 29, 2020) and “MassChallenge Boston Announces 2020 Cohort” (Jun 2, 2020).
Is Cogentis Therapeutics still active?
Yes, Cogentis Therapeutics is active; its latest activity on Parsers VC dates from Sep 29, 2020.